Skip to main content

NCICB Seeks Comment, Geospiza, Oracle Life Sciences Users Group Meeting, NCI, FDA Host Biomarker Workshop


NCICB Seeks Comment on Data Standards Draft

The National Cancer Institute Center for Bioinformatics has released for public comment a draft document covering data content standards for clinical and basic science.

NCICB said it commissioned SAIC to review current data content standards in order to prepare the draft, which is available for a two-week public comment period at

NCICB said it plans to incorporate comments and to release a final version of the document by the end of June.

Geospiza Partners with AME, Biomax

Geospiza last week announced reseller partnerships with AME Bioscience and Biomax Solutions.

In the AME deal, Geospiza’s Finch Sequencing Center software system will be bundled with refurbished or pre-owned sequencing instruments from Applied Biosystems and Amersham Bioscience (Now GE Healthcare).

Under the Biomax agreement, the firms will integrate sell their software together in a package called the Optimized Research Environment.

Oracle Holds Life Science User Group Meeting

Oracle will be hosting its fourth Oracle Life Sciences Users Group Meeting, June 23-24 in Reston, Va.

A full agenda and registration information are available at

NCI, FDA Host Biomarker Validation Workshop

The National Cancer Institute and the Food and Drug Administration will host a workshop in Bethesda, Md., on July 28-29 called, “Research Strategies, Study Designs and Statistical Approaches to Biomarkers Validation for Cancer Diagnosis and Detection.”

The workshop will address study design, statistical methodologies, and validation approaches to cancer biomarkers, and consider approaches to their validation for clinical utility.

A major goal of the workshop, according to the organizers, is “to develop a position paper on state-of-the-art in biomarker validation study.”

Additional information is available at

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.